Larvol Delta - Novartis-bolsters-latestage-cardiovascular-pipeline-with-agreement-to-acquire-Anthos-Therapeutics-for-USD-925-million-upfront

abelacimab (MAA868) - Anthos Therap

https://www.novartis.com/news/media-releases/novartis-bolsters-late-stage-cardiovascular-pipeline-agreement-acquire-anthos-therapeutics-usd-925-million-upfront

Feb 11, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next